Tag ~life sciences

Tag descriptions coming soon to Wherrelz News!


Former Microsoft exec Stefan Weitz wants to build authentic startups and hes starting with probiotics

Health benefits platform Accolade to acquire virtual primary care startup PlushCare in 450M deal

Generate Biomedicines raises 370M Series B with a focus on proteinbased drugs

Startup Aminex Therapeutics raises 10M begins clinical trials of immunotherapy treatment

Twistle raises 16M to automate how healthcare providers talk to patients

Healthcare data startup Truveta showcases new platform and has now raised close to 200M

Health tech company Accolade goes public at 12B valuation in Seattles first IPO of 2020

Gates Wellcome and Mastercard launch 125 million fund to finance COVID19 treatments

Atomwises machine learningbased drug discovery service raises 123 million

Amazon rolling out WorkingWell program to reduce injuries among operations employees

Tech vets launch MultiScale Health aiming to liberate healthcare data with realtime platform

Presage Biosciences raises 6M for technology to test new cancer drugs appoints new CEO

Microsoftbacked universal blood test could start diagnosing disease within a small number of years

Healthcare tech company Accolade raises another 50M total funding tops 200M

Quantori is building an app development platform focused on life sciences

Microsoft will use AI to supercharge Novartis giant drugdevelopment engine

SEngine Precision Medicine raises 3M adds former Fred Hutch president to board

AI2 spinout MajorBoost uses artificial intelligence to help medical providers deal with insurance calls

Alpine raises 91M to fuel the Seattle biotechs clinical trials for lupus and cancer

Seattle biotech startup raises 20M to develop gene therapy technology

Rapid COVID19 test maker Anavasi Diagnostics lands funding from National Institutes of Health

Celgene CEO: Treating cancer is becoming ironically easy now the problem is affordability

Seattlebased health software company Valant sold to another private equity firm

Genneve to launch unique telehealth service for women experiencing menopause

AdaptX raises 6M changes name from MDMetrix expands quest for healthcare data insights

Startup Spotlight: GrailAI hopes to use AI to detect cancers most subtle red flags

OncoResponse raises 40M to start clinical trials of antibodybased cancer immunotherapies

98point6 brings AIfueled telemedicine to Sams Club members

The Fight Is In Us blood plasma campaign deploys Microsoft bot in search of COVID19 antibodies

Cell therapy startup Immusoft lands deal with Takeda worth potentially more than 900M

TLDR: Amazons blue crew delivery Amazon agrees to acquire PillPack Coinme installs 50th Bitcoin ATM

Synthetic biology startups are giving investors an appetite

Vimly Benefit Solutions raises 67M to help healthcare companies manage employee benefits

Seattlearea psychedelics startup CaaMTech raises 22M to advance to human testing

Wellfunded stealthy biotech startup Nautilus hires former Smartsheet Isilon GenapSys execs

Amazon JPMorgan and Berkshire reveal CEO for new health venture pick Boston as HQ

Madrona makes another healthcare bet leads 5M round in clinical software startup Ovationio

LabCorps athome COVID19 test kit is the first to be authorized by the FDA

Fred Hutch names Thomas Lynch new president: Were going to make remarkable leaps

Can blockchain heal what ails healthcare Lumedic launches new quest for digital identity standards

How pandemicdriven talent migration will change where biotech companies are located

Seattle biotech startup OncoSenX raises 3M to develop tumorkilling therapeutics

Steth IO launches smartphonebased stethoscope that visualizes heartbeats invented by teenager

Univ of Washington spinout Icosavax raises 51M to fight viruses with computerdesigned vaccines

Ultrapotent nanoparticle COVID19 vaccine with Univ of Wash roots gets 173M for human trials

EchoNous announces 35M in new funding for mini AIdriven ultrasound devices

Astellas Pharma buying Universal Cells for 102M in Seattles third biotech acquisition in a month

Seattlebased Vera Whole Health sells majority stake to private equity firm

Endeavor BioMedicines raises 62 million to combat pulmonary disease

Juno Therapeutics stock surges 50 as Celgene is reportedly in talks to buy the company